已收盤 04-02 16:00:00 美东时间
+0.660
+3.80%
On April 1, 2026, Vor Bio granted stock options for 42,650 shares and RSUs for 9,050 shares to 9 new employees. The options have a 10-year term, exercise price of $17.39, and vest over four years. RSUs also vest over four years, both under the 2023 Inducement Plan.
04-01 21:00
今日重点评级关注:Maxim Group:上调Theriva Biologics评级至"买入",目标价1美元;HC Wainwright & Co.:维持Bicara Therapeutics"买入"评级,目标价从40美元升至42美元
04-01 16:34
药企并购潮来袭!Apellis制药飙升135%,获生化基因公司高额溢价收购;CNTA大涨44%,获礼来收购,减肥药巨头转向睡眠健康领域>>
04-01 16:10
今日重点评级关注:Oppenheimer:维持Alumis"跑赢大市"评级,目标价从50美元升至55美元;美银证券:维持Rocket Pharmaceuticals"买入"评级,目标价从8美元升至9美元
03-31 16:30
Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(1.63) per share which beat the analyst consensus estimate of $(1.64) by 0.61 percent. This is a 81.48 percent increase over losses of $(8.80) per share from the
03-30 21:29
U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan March 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ferguson Enterprises, Hartford Insurance Group and JP Morgan, on Monday. HIGHLIGHT
03-30 15:35
Shares of Vor Biopharma Inc. (NASDAQ: VOR) are trading higher Friday after pricing a $14.05 private placement of 5.4 million shares.
03-27 23:15
BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Phathom, Argan Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 27 (Reuters) - Wall Street's main indexes were on track to open lower
03-27 21:15
Vor Biopharma shares are trading higher after the company announced the pricing...
03-27 20:26
Vor Bio (VOR) said on Friday it had entered a securities purchase agreement to sell 5.34M shares at $14.05 each in a private placement, for gross proceeds of about $75M. The private placement is expec...
03-27 20:20